Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

Molecular epidemiology of Escherichia coli isolated from urinary tract infections in inpatients and outpatients in Gauteng, South Africa

Dissertation (MSc (Medical Microbiology))--University of Pretoria, 2021.

Saved in:
Bibliographic Details
Other Authors: Kock, Martha Magdalena
Format: Thesis
Language:English
Published: University of Pretoria 2022
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1867613591881908224
access_status_str Open Access
author2 Kock, Martha Magdalena
author_browse Kock, Martha Magdalena
author_facet Kock, Martha Magdalena
collection Thesis
dc_rights_str_mv © 2022 University of Pretoria. All rights reserved. The copyright in this work vests in the University of Pretoria. No part of this work may be reproduced or transmitted in any form or by any means, without the prior written permission of the University of Pretoria.
description Dissertation (MSc (Medical Microbiology))--University of Pretoria, 2021.
format Thesis
id oai:repository.up.ac.za:2263/83503
institution University of Pretoria (South Africa)
language English
last_indexed 2026-06-10T12:38:35.295Z
license_str Other — see source repository
provenance_str_mv Harvested via OAI-PMH from UPSpace — University of Pretoria Institutional Repository
publishDate 2022
publishDateRange 2022
publishDateSort 2022
publisher University of Pretoria
publisherStr University of Pretoria
record_format dspace
source_str UPSpace — University of Pretoria Institutional Repository
spelling oai:repository.up.ac.za:2263/83503 Molecular epidemiology of Escherichia coli isolated from urinary tract infections in inpatients and outpatients in Gauteng, South Africa Kock, Martha Magdalena keeganhoog@gmail.com Pitout, Johann Strydom, Kathy-Anne Hoog, Keegan John UCTD Antibiotic resistance Molecular epidemiology One Health Dissertation (MSc (Medical Microbiology))--University of Pretoria, 2021. Urinary tract infections (UTIs) have the highest burden of disease worldwide and disproportionately affects female and elderly patients. The most common causative agent of UTIs is Escherichia coli. Escherichia coli that causes UTIs is classified as extraintestinal pathogenic E. coli (ExPEC) and more specifically uropathogenic E. coli (UPEC). Clear clonality exists amongst ExPEC isolates, and the most dominant clone is the multi-drug resistant sequence type (ST) 131. Between 20% to 30% of all UTIs are caused by ST131 UPEC. The aim of this study was to characterise ST131 and non-ST131 clones in E. coli isolated from urinary specimens in inpatients and outpatients in Gauteng, South Africa. Non-repeat E. coli isolates were collected from a private diagnostic laboratory over a one-week period. Isolate antimicrobial susceptibility results as well as corresponding patient information were collected. Isolates where screened for ST131 and its clades using two multiplex-PCR (M-PCR) assays. Non-ST131 were characterised using a seven single nucleotide polymorphisms RT-PCR (septatyping) assay. All isolates where further screened for colistin susceptibility using a resazurin reduction-based assay with a breakpoint concentration of 3.75 µg/mL. Non-susceptible isolates underwent minimum inhibitory concentration (MIC) determination by broth microdilution assay. Colistin resistant isolates underwent mcr-1 to mcr-5 screening using a M-PCR assay. Of the 428 E. coli isolates that were collected, 18% (n=77/428) were ST131. The proportional distribution of ST131 in outpatients was 20% (n= 54/274) and 18% in inpatients (n= 21/115). The most prevalent ST131 clade was C1 (32.5%; n=25/77) followed by C2 (23.4%; n= 18/77), A (19.5%; n= 15/77), B (13%; n= 10/77) and subclade C1-M27 (5.2%; n=4/77). Two septatypes, 271 and 620, are homogenous with ST69 and ST73 respectively, and were identified in both inpatients and outpatients. Sequence type 131 isolates showed high rates of resistance to ciprofloxacin (CIP) 79% (n= 19/24), levofloxacin (LEV) 84% (n= 16/19) and ciprofloxacin/levofloxacin combination (CIP/LEV), 57% (n= 30/53). Non-ST131 showed a resistance rate of 18% (n= 11/62), 15% (n= 6/40) and 20% (n= 47/239) for ciprofloxacin, levofloxacin, and ciprofloxacin/levofloxacin combination, respectively. The percentage of extended spectrum beta-lactamase (ESBL) producing isolates was 32% (n= 23/72) for ST131 isolates and 6% (n= 17/291) in non-ST131 isolates. Three isolates were resistant to colistin and had a MIC of 16 µg/mL. None of the colistin resistant isolates screened positive for mcr-1 to mcr 5 genotypes. This study was the first in South Africa to report the prevalence of ST131 and its clades from an ExPEC sample without an antibiotic resistance sampling bias. The prevalence of ST131 in UPEC limits the choice for effective antibiotic treatment. Better techniques for surveillance of ExPEC clones, such as a sequence-based methods, would effectively identify high-risk ExPEC clones, their associated antibiotic resistance genes, and the ability to perform horizontal gene transfer using mobile genetic vectors. This would allow for the implementation of better infection prevention and control strategies to stop the spread of these genes to environmental and or animal Enterobacteriaceae, contributing to the “One Health” model. RESCOM Short Term Research Grant at the University of Pretoria Medical Microbiology MSc (Medical Microbiology) Unrestricted 2022-01-28T08:47:12Z 2022-01-28T08:47:12Z 2022-04 2021 Dissertation * A2022 http://hdl.handle.net/2263/83503 en © 2022 University of Pretoria. All rights reserved. The copyright in this work vests in the University of Pretoria. No part of this work may be reproduced or transmitted in any form or by any means, without the prior written permission of the University of Pretoria. application/pdf University of Pretoria
spellingShingle UCTD
Antibiotic resistance
Molecular epidemiology
One Health
Molecular epidemiology of Escherichia coli isolated from urinary tract infections in inpatients and outpatients in Gauteng, South Africa
title Molecular epidemiology of Escherichia coli isolated from urinary tract infections in inpatients and outpatients in Gauteng, South Africa
title_full Molecular epidemiology of Escherichia coli isolated from urinary tract infections in inpatients and outpatients in Gauteng, South Africa
title_fullStr Molecular epidemiology of Escherichia coli isolated from urinary tract infections in inpatients and outpatients in Gauteng, South Africa
title_full_unstemmed Molecular epidemiology of Escherichia coli isolated from urinary tract infections in inpatients and outpatients in Gauteng, South Africa
title_short Molecular epidemiology of Escherichia coli isolated from urinary tract infections in inpatients and outpatients in Gauteng, South Africa
title_sort molecular epidemiology of escherichia coli isolated from urinary tract infections in inpatients and outpatients in gauteng south africa
topic UCTD
Antibiotic resistance
Molecular epidemiology
One Health
url http://hdl.handle.net/2263/83503